论文部分内容阅读
俄罗斯商务咨询网站9月3日报道,据俄罗斯《生意人报》的消息,俄罗斯可能限制政府采购国外生产的药品。由俄罗斯工业和贸易部起草的相关法案表明,限制采购的将是不在关税同盟成员国生产的药品。因此,来自俄罗斯,哈萨克斯坦和白俄罗斯的药品生产可能申请参加药品国家招标,来自其他国家的公司不能参加招标。此举是为了保护俄罗斯国内市场,发展民族经济,支持俄罗斯生产商,扩大在俄罗斯进行本地化生产的外资药企数量。法案制定者认
Russia Business Consulting website reported on September 3, according to the Russian “Business Daily” news, Russia may limit the government procurement of drugs produced abroad. Related bills drafted by the Russian Ministry of Industry and Trade show that restrictions on purchases will be for medicines that are not manufactured in Customs Union member countries. As a result, pharmaceutical production from Russia, Kazakhstan and Belarus may apply for bidding in participating countries and companies from other countries will not be able to participate in the bidding. The move is aimed at protecting the Russian domestic market, developing the national economy, supporting Russian producers and expanding the number of foreign-funded pharmaceutical companies that are producing locally in Russia. Act makers recognize